Allen J C, Entman M L, Schwartz A
J Pharmacol Exp Ther. 1975 Jan;192(1):105-12.
Ouabain interaction with a possible pharmacologic receptor, Na+, K+-adenosine triphosphatase (Na+, K+-ATPase), has been assessed by continual perfusion of canine hearts with various concentrations of both unlabeled and 3-H-ouabain. A positive dose-related correlation between enzyme inhibition, increased contractile force and drug binding to the enzyme has been established. The complex formed between 3-H-oubain and Na+, K+-ATPase in vivo appears to have the same characteristics as that formed in vitro, suggesting that the nature of both complexes is the same. These data are consistent with the concept that Na+, K+-ATPase may be an important pharmacologic receptor for cardiac glycosides.
通过用不同浓度的未标记哇巴因和3-H-哇巴因持续灌注犬心脏,评估了哇巴因与一种可能的药理学受体——钠钾腺苷三磷酸酶(Na⁺,K⁺-ATP酶)的相互作用。已确定酶抑制、收缩力增加与药物与酶的结合之间存在正剂量相关关系。体内3-H-哇巴因与Na⁺,K⁺-ATP酶形成的复合物似乎具有与体外形成的复合物相同的特征,这表明两种复合物的性质相同。这些数据与Na⁺,K⁺-ATP酶可能是强心苷重要药理学受体的概念一致。